These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 29699895)
21. Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP). Ohnuma T; Sakai Y; Maeshima H; Hatano T; Hanzawa R; Abe S; Kida S; Shibata N; Suzuki T; Arai H Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1905-12. PubMed ID: 18835577 [TBL] [Abstract][Full Text] [Related]
22. Feasibility and effectiveness of a cognitive remediation programme with original computerised cognitive training and group intervention for schizophrenia: a multicentre randomised trial. Matsuda Y; Morimoto T; Furukawa S; Sato S; Hatsuse N; Iwata K; Kimura M; Kishimoto T; Ikebuchi E Neuropsychol Rehabil; 2018 Apr; 28(3):387-397. PubMed ID: 27150346 [TBL] [Abstract][Full Text] [Related]
23. Neurocognitive and Self-efficacy Benefits of Cognitive Remediation in Schizophrenia: A Randomized Controlled Trial. Bryce SD; Rossell SL; Lee SJ; Lawrence RJ; Tan EJ; Carruthers SP; Ponsford JL J Int Neuropsychol Soc; 2018 Jul; 24(6):549-562. PubMed ID: 29352823 [TBL] [Abstract][Full Text] [Related]
24. No correlation between plasma NMDA-related glutamatergic amino acid levels and cognitive function in medicated patients with schizophrenia. Ohnuma T; Sakai Y; Maeshima H; Higa M; Hanzawa R; Kitazawa M; Hotta Y; Katsuta N; Takebayashi Y; Shibata N; Arai H Int J Psychiatry Med; 2012; 44(1):17-27. PubMed ID: 23356091 [TBL] [Abstract][Full Text] [Related]
25. Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment. Yamamori H; Hashimoto R; Fujita Y; Numata S; Yasuda Y; Fujimoto M; Ohi K; Umeda-Yano S; Ito A; Ohmori T; Hashimoto K; Takeda M Neurosci Lett; 2014 Oct; 582():93-8. PubMed ID: 25218715 [TBL] [Abstract][Full Text] [Related]
26. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. Vinogradov S; Fisher M; Warm H; Holland C; Kirshner MA; Pollock BG Am J Psychiatry; 2009 Sep; 166(9):1055-62. PubMed ID: 19570929 [TBL] [Abstract][Full Text] [Related]
27. Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Vita A; Barlati S; Ceraso A; Nibbio G; Ariu C; Deste G; Wykes T JAMA Psychiatry; 2021 Aug; 78(8):848-858. PubMed ID: 33877289 [TBL] [Abstract][Full Text] [Related]
28. When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Adcock RA; Dale C; Fisher M; Aldebot S; Genevsky A; Simpson GV; Nagarajan S; Vinogradov S Schizophr Bull; 2009 Nov; 35(6):1132-41. PubMed ID: 19745022 [TBL] [Abstract][Full Text] [Related]
29. Individual Alpha Peak Frequency Moderates Transfer of Learning in Cognitive Remediation of Schizophrenia. Castelluccio BC; Kenney JG; Johannesen JK J Int Neuropsychol Soc; 2020 Jan; 26(1):19-30. PubMed ID: 31983373 [TBL] [Abstract][Full Text] [Related]
30. Auditory Cortical Plasticity Drives Training-Induced Cognitive Changes in Schizophrenia. Dale CL; Brown EG; Fisher M; Herman AB; Dowling AF; Hinkley LB; Subramaniam K; Nagarajan SS; Vinogradov S Schizophr Bull; 2016 Jan; 42(1):220-8. PubMed ID: 26152668 [TBL] [Abstract][Full Text] [Related]
31. The impact of intrinsic motivation on session attendance and reliable cognitive improvement in cognitive remediation in schizophrenia. Bryce SD; Lee SJ; Ponsford JL; Lawrence RJ; Tan EJ; Rossell SL Schizophr Res; 2018 Dec; 202():354-360. PubMed ID: 29935884 [TBL] [Abstract][Full Text] [Related]
32. Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Vita A; Barlati S; Ceraso A; Nibbio G; Durante F; Facchi M; Deste G; Wykes T Am J Psychiatry; 2024 Jun; 181(6):520-531. PubMed ID: 38476043 [TBL] [Abstract][Full Text] [Related]
33. Improving cognitive training for schizophrenia using neuroplasticity enhancers: Lessons from decades of basic and clinical research. Guercio GD; Thomas ME; Cisneros-Franco JM; Voss P; Panizzutti R; de Villers-Sidani E Schizophr Res; 2019 May; 207():80-92. PubMed ID: 29730045 [TBL] [Abstract][Full Text] [Related]
34. The relationship between change in cognition and change in functional ability in schizophrenia during cognitive and psychosocial rehabilitation. Rispaud SG; Rose J; Kurtz MM Psychiatry Res; 2016 Oct; 244():145-50. PubMed ID: 27479105 [TBL] [Abstract][Full Text] [Related]
35. Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms. Sumiyoshi T; Anil AE; Jin D; Jayathilake K; Lee M; Meltzer HY Int J Neuropsychopharmacol; 2004 Mar; 7(1):1-8. PubMed ID: 14720317 [TBL] [Abstract][Full Text] [Related]
36. High-intensity interval training and active video gaming improve neurocognition in schizophrenia: a randomized controlled trial. Bang-Kittilsen G; Egeland J; Holmen TL; Bigseth TT; Andersen E; Mordal J; Ulleberg P; Engh JA Eur Arch Psychiatry Clin Neurosci; 2021 Mar; 271(2):339-353. PubMed ID: 33156372 [TBL] [Abstract][Full Text] [Related]
37. Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine. Kantrowitz JT; Epstein ML; Beggel O; Rohrig S; Lehrfeld JM; Revheim N; Lehrfeld NP; Reep J; Parker E; Silipo G; Ahissar M; Javitt DC Brain; 2016 Dec; 139(Pt 12):3281-3295. PubMed ID: 27913408 [TBL] [Abstract][Full Text] [Related]
38. Early auditory processing abnormalities alter individual learning trajectories and sensitivity to computerized cognitive training in schizophrenia. Molina JL; Joshi YB; Nungaray JA; Sprock J; Attarha M; Biagianti B; Thomas ML; Swerdlow NR; Light GA Psychol Med; 2024 Jul; 54(10):2669-2676. PubMed ID: 38587021 [TBL] [Abstract][Full Text] [Related]
39. BDNF as a marker of response to cognitive remediation in patients with schizophrenia: A randomized and controlled trial. Penadés R; López-Vílchez I; Catalán R; Arias B; González-Rodríguez A; García-Rizo C; Masana G; Ruíz V; Mezquida G; Bernardo M Schizophr Res; 2018 Jul; 197():458-464. PubMed ID: 29274733 [TBL] [Abstract][Full Text] [Related]
40. Enhancing Cognitive Training Through Aerobic Exercise After a First Schizophrenia Episode: Theoretical Conception and Pilot Study. Nuechterlein KH; Ventura J; McEwen SC; Gretchen-Doorly D; Vinogradov S; Subotnik KL Schizophr Bull; 2016 Jul; 42 Suppl 1(Suppl 1):S44-52. PubMed ID: 27460618 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]